Back to All Events

2027 Best of Hematology - Portsmouth


  • The Venue at Portwalk Place 22 Portwalk Place Portsmouth, New Hampshire, 03801 United States (map)

In-Person Access Only | 7.00 CE/CME Credits & MOC Points

Please read: All programs remain free. Registrations will require a credit card as a cancellation hold. A fee of $99 will only be incurred in the event of a no-show or cancellation within 5 days without written confirmation to the Total Health Program Team. Industry representatives—defined as any individual who is employed by, contracted with, owns, or represents a drug, device, diagnostic, or other healthcare-related commercial entity, regardless of clinical credentials or licensure—are not permitted to attend Total Health events as general attendees. Members of industry must contact exhibits@totalhealthoncology.com

We invite you to join us for the Best of Hematology conference in Portsmouth, NH happening simultaneously with the 4th Annual Best of Hematology in Vail, CO. This innovative and state of the art program will feature some of the world's leading hematologists to present the latest research and strategies for the care of hematological malignancies — incorporating data from the major oncologic annual meetings.

 

Conference Agenda
Saturday, February 6, 2027

Program Chairs:
Hamza Hasmi, MD | Memorial Sloan Kettering Cancer Center
Frederick Lansigan, MD
| Dartmouth Health

7:15 AM - 7:45 AM
Coffee and Registration

7:45 AM - 8:15 AM
Breakfast and Exhibits

8:15 AM - 9:00 AM
Non-CME Breakfast - Pfizer ACEDTRIS

9:00 AM - 9:20 AM
Coffee Break and Networking
‍ ‍

9:20 AM - 9:30 AM
Welcome and Opening Remarks


9:30 AM - 10:00 AM
Acute Leukemias in 2027: MRD-Guided Therapy, Cellular Immunotherapy, and Emerging Treatment Strategies in AML and ALL

Evan Chen, MD | Dana-Farber Cancer Institute

10:00 AM - 10:30 AM
CLL: Fixed-Duration Therapy, BTK Degraders, and Treatment Sequencing

Frederick Lansigan, MD | Dartmouth Health

10:30 AM - 10:40 AM
Coffee Break and Networking

10:40 AM - 11:10 AM
DLBCL Beyond R-CHOP: How Are Bispecifics and CAR-T Moving Earlier?

Hari Raman, MD, MBA | Dana-Farber Cancer Institute

11:10 AM - 11:40 AM
Follicular and Indolent Lymphomas: When to Use Bispecifics, CAR-T, and Novel Immune Therapies
Anne Beaven, MD | UNC

11:40 AM - 12:10 PM
Sickle Cell Disease
Scott Peslak, MD, PhD | Penn Medicine

12:10 PM - 12:20 PM
Housekeeping and Survey


12:20 PM - 12:40 PM
Lunch and Exhibits

12:40 PM - 1:25 PM
Non-CME Lunch

1:25 PM - 1:55 PM
Coffee Break and Networking

1:55 PM - 2:55 PM
Extended Panel Discussion: Practice-Changing Hematology Abstracts 2026-2027: What Will Change Monday Morning?

Frederick Lansigan, MD | Dartmouth Health (Moderator)
Anne Beaven, MD | UNC
Scott Peslak, MD, PhD | Penn Medicine
Evan Chen, MD | Dana-Farber Cancer Institute
Hari Raman, MD, MBA | Dana-Farber Cancer Institute

2:55 PM
ADJOURN

Sunday, February 7, 2027

7:15 AM - 7:45 AM
Coffee and Registration

7:45 AM - 8:15 AM
Breakfast and Exhibits

8:15 AM - 9:00 AM
Non-CME Breakfast - Pfizer ELREXFIO

9:00 AM - 9:20 AM
Coffee Break and Networking
‍ ‍

9:20 AM - 9:30 AM
Welcome and Opening Remarks


9:30 AM - 10:00 AM
Multiple Myeloma: Sequencing BCMA and GPRC5D Therapies in Clinical Practice

Hamza Hashmi, MD | Memorial Sloan Kettering Cancer Center

10:00 AM - 10:30 AM
Time-Limited Maintenance: Is Continuous Therapy Still the Standard?

10:30 AM - 10:40 AM
Coffee Break and Networking

10:40 AM - 11:10 AM
MDS and MPNs: New Standards of Care and Emerging Disease-Modifying Strategies

Shyam Patel, MD, PhD | U Mass Medicine

11:10 AM - 11:40 AM
Benign Hematology in 2027: Advances in Thrombosis, Anticoagulation, and Bleeding Disorders

11:40 AM - 12:10 PM
Navigating Rare Lymphoid Malignancies: Current Approaches to PTLD, CNS Lymphomas, and HIV-Related Lymphomas
Nina Wagner-Johnston, MD | Johns Hopkins Medicine

12:10 PM - 12:20 PM
Housekeeping and Survey


12:20 PM - 12:40 PM
Lunch and Exhibits

12:40 PM - 1:25 PM
Non-CME Lunch

1:25 PM - 1:55 PM
Coffee Break and Networking

1:55 PM - 2:55 PM
Extended Panel Discussion: How Are You Actually Integrating Novel Hematology Therapies Into Practice?

Hamza Hashmi, MD | Memorial Sloan Kettering Cancer Center (Moderator)
Nina Wagner-Johnston, MD | Johns Hopkins Medicine
Shyam Patel, MD, PhD | U Mass Medicine

2:55 PM
ADJOURN

Agenda Subject To Change. All times are EST.

 
 
Previous
Previous
January 30

2027 West Oncology Conference

Next
Next
February 12

2027 Debating Lung Symposium